Home/ Supplements/ Omega 3/ Alaska Deep Sea Fish Oil

Alaska Deep Sea Fish Oil

product on market Softgel Capsule NCB Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

EPA and DHA omega-3 fatty acids have strong evidence for supporting cardiovascular health and cognitive function. Vitamin E acts as an antioxidant to protect these oils from oxidation. Research generally supports the efficacy of these ingredients, though overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Alaska Deep Sea Fish Oil
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Softgel(s)
Serving Size
Fat/Fatty Acid
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Fish Body Oil
2000 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
2 IU
Within RDA (0.1× RDA) 179 studies (A:3, B:90)
Claims

Label Claims — Verification

Unverified No Claim
Info

Product Information

Directions for Use

ADMINISTRATION & DOSAGE As a food supplement, take 2 softgel daily with water after meals or as recommended by your health care professional.

Formulation Notes

PURE EPA & DHA

Sugar, starch & preservative free.

Additional Information

NATURAL OMEGA-3,6,9

NATURAL MARINE LIPID CONCENTRATE

NCB Alaska Deep Sea Fish Oil (1g, 100 softgels) D0201

STORAGE Should be kept in a dry place and protected from light and heat.

[D0201]

Metadata

Product Details

DSLD Entry Date2012-10-01
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandNCB
DSLD ID13732
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.